Viridian Therapeutics, Inc. (VRDN)
29.93
-1.51
(-4.80%)
USD |
NASDAQ |
Nov 20, 16:00
29.93
0.00 (0.00%)
After-Hours: 20:00
Viridian Therapeutics Gross Profit (TTM) : 23.88M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 23.88M |
| June 30, 2026 | 70.26M |
| March 31, 2026 | 69.85M |
| December 31, 2025 | 69.59M |
| September 30, 2025 | 69.73M |
| June 30, 2025 | -0.778M |
| March 31, 2025 | -1.01M |
| December 31, 2024 | -1.038M |
| September 30, 2024 | -1.265M |
| June 30, 2024 | -1.284M |
| March 31, 2024 | -1.174M |
| December 31, 2023 | -1.008M |
| September 30, 2023 | -0.73M |
| June 30, 2023 | -0.467M |
| March 31, 2023 | -0.008M |
| December 31, 2022 | 0.175M |
| September 30, 2022 | -0.243M |
| June 30, 2022 | -0.243M |
| March 31, 2022 | -0.342M |
| December 31, 2021 | -0.418M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.20M |
| March 31, 2021 | -0.20M |
| December 31, 2020 | -0.20M |
| September 30, 2020 | -0.20M |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 4.715M |
| September 30, 2018 | 4.715M |
| June 30, 2018 | 4.715M |
| March 31, 2018 | 4.715M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.064M |
| June 30, 2017 | 0.354M |
| March 31, 2017 | 0.60M |
| December 31, 2016 | 0.789M |
| September 30, 2016 | 0.928M |
| June 30, 2016 | 0.562M |
| March 31, 2016 | 0.372M |
| December 31, 2015 | 0.068M |
| September 30, 2015 | -0.3903M |
| June 30, 2015 | 0.1152M |
| March 31, 2015 | 0.657M |
| December 31, 2014 | 1.168M |
| September 30, 2014 | 1.800M |
| June 30, 2014 | 1.682M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Travere Therapeutics, Inc. | 588.71M |
| Arrowhead Pharmaceuticals, Inc. | 422.57M |
| Vertex Pharmaceuticals, Inc. | 11.15B |
| TG Therapeutics, Inc. | 742.84M |
| ACADIA Pharmaceuticals, Inc. | 1.088B |